Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer

Abstract

The prognosis for locally advanced gastric cancer (AGC) remains unsatisfactory, even with S-1 adjuvant chemotherapy. We investigated the efficacy of neoadjuvant chemotherapy consisting of docetaxel, cisplatin and S-1 (DCS). We retrospectively reviewed 59 patients who underwent neoadjuvant DCS therapy for clinical stage III tumors or serosa-positive tumors… (More)
DOI: 10.1007/s10147-015-0851-2

Topics

8 Figures and Tables

Cite this paper

@article{Migita2015EfficacyON, title={Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer}, author={Kazuhiro Migita and Atsushi Nashimoto and Hiroshi Yabusaki and Atsushi Matsuki and Masaki Aizawa}, journal={International Journal of Clinical Oncology}, year={2015}, volume={21}, pages={102-109} }